Graf Akcie CDNA (Caredx Inc). Diskuze k akciím CDNA. Aktuální informace CDNA.

Základní informace o společnosti Caredx Inc (Akcie CDNA)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 3.26B
Hodnota podniku (EV) N/A
Tržby 253.601M
EBITDA N/A
Zisk -8.95
Růst v tržbách Q/Q 77.48 %
Růst v tržbách Y/Y 69.28 %
P/E (Cena vůči ziskům) 0.00
Forward P/E 243.37
EV/Sales 14.26
EV/EBITDA N/A
EV/EBIT N/A
PEG 7.00
Price/Sales 12.85
P/FCF N/A
Price/Book 11.74
Účetní hodnota na akcii 5.33
Hotovost na akcii 4.32
FCF vůči ceně -0.59 %
Počet zaměstnanců 466
Tržba na zaměstnance 544.208k
Profit margin -9.74 %
Operating margin -4.56 %
Gross margin 67.16 %
EBIT margin -3.94 %
EBITDA margin -10.87 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 175.00 %
EPS - Očekávaný růst příští rok -80.00 %
Return on assets -1.97 %
Return on equity -2.39 %
ROIC -7.70 %
ROCE -1.99 %
Dluhy/Equity 0.33
Čistý dluh/EBITDA 24.20
Current ratio 7.84
Quick Ratio 7.57
Volatilita 5.70
Beta 1.85
RSI 42.92
Cílová cena analytiků 59
Známka akcie (dle analytiků) N/A
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 52.627M
Procento shortovaných akcií 9.57 %
Short ratio 9.37 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2014
Země United States

Finanční výsledky akcie CDNA

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$127.068$76.569$48.324$40.631$28.144$27.306$22.098$20.451
Cost Of Goods Sold$45.455$32.987$21.371$21.122$10.273$8.541$9.078$7.93
Gross Profit$81.613$43.582$26.953$19.509$17.871$18.765$13.02$12.521
Research And Development Expenses$30.711$14.514$12.388$12.385$9.333$3.846$3.176$4.752
SG&A Expenses$75.434$44.646$32.901$31.891$20.596$14.908$10.701$10.111
Other Operating Income Or Expenses---$0.456$0.126$1.239--
Operating Expenses$151.6$92.147$68.618$77.963$40.076$26.056$22.955$22.793
Operating Income$-24.532$-15.578$-20.294$-37.332$-11.932$1.25$-0.857$-2.342
Total Non-Operating Income/Expense$0.585$-32.637$-36.975$-4.03$-1.775$-1.969$-2.685$-2.717
Pre-Tax Income$-23.947$-48.215$-57.269$-41.362$-13.707$-0.719$-3.542$-5.059
Income Taxes$-1.979$-1.434$-1.709$-1.606-$-1.5--
Income After Taxes$-21.968$-46.781$-55.56$-39.756$-13.707$0.781$-3.542$-5.059
Other Income--------
Income From Continuous Operations$-21.968$-46.781$-55.56$-39.756$-13.707$0.781$-3.542$-5.059
Income From Discontinued Operations--------
Net Income$-21.968$-46.756$-55.469$-39.469$-13.707$0.781$-3.542$-5.059
EBITDA$-19.009$-8.897$-12.697$-30.383$-11.019$1.834$0.166$-0.823
EBIT$-24.532$-15.578$-20.294$-37.332$-11.932$1.25$-0.857$-2.342
Basic Shares Outstanding4236231612611
Shares Outstanding4236231612911
Basic EPS$-0.52$-1.31$-2.38$-2.39$-1.16$0.13$-3.50$-5.01
EPS - Earnings Per Share$-0.52$-1.31$-2.38$-2.39$-1.16$0.10$-3.50$-5.01
# 2020 2019 2018 2017 2016 2015
Current Ratio2.06514.15880.62390.65323.38483.6234
Long-term Debt / Capital--1.48080.05260.30410.1166
Debt/Equity Ratio---5.72041.21170.53410.2763
Gross Margin64.227856.918655.775648.015163.498468.7212
Operating Margin-19.3062-20.3451-41.9957-91.8806-42.39634.5777
EBIT Margin-19.3062-20.3451-41.9957-91.8806-42.39634.5777
EBITDA Margin-14.9597-11.6196-26.2747-74.7779-39.15226.7165
Pre-Tax Profit Margin-18.8458-62.9694-118.5105-101.7991-48.7031-2.6331
Net Profit Margin-17.2884-61.0639-114.7856-97.1401-48.70312.8602
Asset Turnover0.83740.58590.57830.52950.50580.4466
Inventory Turnover Ratio7.55826.67353.86533.867813.411212.4504
Receiveable Turnover5.2827.845216.156514.678811.890210.1623
Days Sales In Receivables69.103246.525422.591624.865730.697735.9172
ROE - Return On Equity-22.1899-48.7668933.1539-201.1841-46.47391.8911
Return On Tangible Equity-74.2112-92.323108.7322146.151-126.463.4492
ROA - Return On Assets-14.4778-35.7935-66.4872-51.8129-24.6361.2774
ROI - Return On Investment-22.1899-48.7668-448.6434-190.594-32.34231.6706
Book Value Per Share2.32952.3179-0.20660.92872.47813.4986
Operating Cash Flow Per Share0.04670.50080.3884-0.1794-0.46130.1792
Free Cash Flow Per Share0.05160.45160.4138-0.1116-0.48350.1972

Porovnání s konkurencí: Akcie CDNA

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
CDNA 0.00 7.00 69.28 % -80.00 % -2.39 % 11.74 -9.74 %
Akcie AGIO 1.94 N/A N/A % 11.19 % 129.96 % 6.48 -161.11 %
Akcie ARDX 0.00 N/A 49.39 % 70.00 % -99.11 % 0.99 -1,245.71 %
Akcie TTOO 0.00 N/A 171.09 % 0.00 % -510.02 % 14.84 -258.12 %

Nedávné obchody insiderů: Akcie CDNA

Jméno Obchod Cena Objem
Peter Maag
Executive Chair
Option
5 Nov 2020
$6.08 $60,800
William A Hagstrom
Director
Option
12 Nov 2020
$6.50 $65,000
Peter Maag
Executive Chair
Option
7 Dec 2020
$6.31 $63,100
George Bickerstaff
Director
Prodej
14 Dec 2020
$71.76 $717,600
Michael Goldberg
Director
Prodej
14 Dec 2020
$70.19 $2,105,700
Reginald Seeto
See Remarks
Prodej
18 Dec 2020
$68.01 $568,768
Peter Maag
Executive Chair
Option
5 Jan 2021
$6.31 $63,100
Fred E Cohen
Director
Option
6 Jan 2021
$14.74 $221,100
Sasha King
Chief Marketing Officer
Option
14 Jan 2021
$9.20 $90,850
Ralph Snyderman
Director
Prodej
15 Jan 2021
$88.88 $1,066,560
Peter Maag
Executive Chair
Prodej
3 Feb 2021
$89.82 $898,200

Diskuze k akciím CDNA